Cargando…

A Novel Approach for Identifying Ischemic Cardiomyopathy

Detalles Bibliográficos
Autor principal:	Choi, Eui-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720844/ https://www.ncbi.nlm.nih.gov/pubmed/26798380 http://dx.doi.org/10.4070/kcj.2016.46.1.13

Ejemplares similares

Feature Tracking Analysis, the “Cherry-on-Top” of Cardiac Magnetic Resonance for Suspected Iron Overload Cardiomyopathy
por: Choi, Eui-Young
Publicado: (2021)

Non-ischemic cardiomyopathy in the elderly: A shocking conundrum
por: Padmanabhan, Deepak, et al.
Publicado: (2019)

Cardiovascular dynamics in ischemic cardiomyopathy during exercise
por: van der Wall, E. E., et al.
Publicado: (2009)

Identified Three Interferon Induced Proteins as Novel Biomarkers of Human Ischemic Cardiomyopathy
por: Chen, Cheng, et al.
Publicado: (2021)

Editorial of Special Issue “Genetics and Molecular Pathogenesis of Non-Ischemic Cardiomyopathies”
por: Lombardi, Raffaella, et al.
Publicado: (2020)

Echocardiography in takotsubo cardiomyopathy; a useful approach?
por: van der Wall, E. E., et al.
Publicado: (2010)

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2023)

Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?
por: Graber, Michael, et al.
Publicado: (2022)

Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development
por: Leitão, Jorge H., et al.
Publicado: (2020)

How to use intracardiac echocardiography to identify ventricular tachycardia substrate in ischemic cardiomyopathy
por: Briceño, David F., et al.
Publicado: (2020)

Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?
por: van der Wall, E. E.
Publicado: (2009)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

Critical Role of Cardiopulmonary Point-of-Care Ultrasound in the Era of COVID-19
por: Choi, Eui-Young
Publicado: (2021)

Human epididymis protein 4: a novel predictor of ischemic cardiomyopathy
por: Tang, Yi, et al.
Publicado: (2021)

Multimodality Imaging in Ischemic Cardiomyopathy
por: Prior, John O., et al.
Publicado: (2014)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
por: Portokallidou, Konstantina, et al.
Publicado: (2023)

Targeting mAKAPβ Expression as a Therapeutic Approach for Ischemic Cardiomyopathy
por: Martinez, Eliana C., et al.
Publicado: (2023)

Aging and ischemic stroke
por: Yousufuddin, Mohammed, et al.
Publicado: (2019)

Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy
por: Siontis, Konstantinos C., et al.
Publicado: (2019)

Emergence of endocardium/epicardium flow gradient as novel risk biomarker in patients with hypertrophic cardiomyopathy
por: Schindler, Thomas H., et al.
Publicado: (2020)

Mapping of ventricular tachycardia in patients with ischemic cardiomyopathy: Current approaches and future perspectives
por: Pandozi, Claudio, et al.
Publicado: (2019)

Delayed-enhanced magnetic resonance imaging for identifying the ventricular arrhythmia substrate in non-ischemic cardiomyopathy
por: Desjardins, Benoit, et al.
Publicado: (2009)

Social Inequalities in Non-ischemic Cardiomyopathies
por: Amiya, Eisuke
Publicado: (2022)

Epicardial–Endocardial Reentry in Ischemic Cardiomyopathy
por: Kotake, Yasuhito, et al.
Publicado: (2021)

Multimodality Imaging in Ischemic Chronic Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2022)

Accurate Classification of Non-ischemic Cardiomyopathy
por: Wang, Yifan, et al.
Publicado: (2023)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Prognostic Implications of Left Ventricular Global Longitudinal Strain in Dilated Cardiomyopathy
por: Park, Mi Young
Publicado: (2020)

Non-Ischemic Cardiomyopathy Attributed to Adult Myotonic Dystrophy
por: Park, Hyun Kyung, et al.
Publicado: (2009)

The preterm heart: a unique cardiomyopathy?
por: Lewandowski, Adam J.
Publicado: (2019)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Cardiomyopathies—past, present, future
por: Maisch, Bernhard, et al.
Publicado: (2020)

Insights on Infiltrative and Restrictive Cardiomyopathies
por: Trachtenberg, Barry, et al.
Publicado: (2022)

What’s New in Arrhythmogenic Cardiomyopathies
por: Çimen, Tolga, et al.
Publicado: (2022)

Establishment of a Novel Murine Model of Ischemic Cardiomyopathy with Multiple Diffuse Coronary Lesions
por: Nakaoka, Hajime, et al.
Publicado: (2013)

Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy
por: Wang, Jinhui, et al.
Publicado: (2018)

Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach
por: Arsenos, Petros, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k3s6f82c52411q2h3g8epkccns